ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1218

Genetic Markers of Functional Stress Response in Patients with Rheumatoid Arthritis

Olga Malysheva and Christoph G. Baerwald, Rheumatology, University Hospital, Leipzig, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Autonomic disorders, Rheumatoid arthritis (RA) and stress

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Stress is recognized as an important risk factor in the pathogenesis of rheumatoid arthritis (RA). However, it is still incompletely understood how the stress response and interactions between the autonomic nervous system, the hypothalamus-pituitary-adrenal axis and the immune system contributes to the pathogenesis of RA. The purpose of our study was to characterise neuroimmune interactions common variants in the genes of the beta2-adrenergic receptor (beta2AR) and corticotropin releasing hormone (CRH) together with functional stress responses in RA patients and controls.

Methods: An allele-specific polymerase chain reaction was used to determine the polymorphisms of the beta2AR at position 16, 27, and 164, as well as the polymorphic sequences in the 5′ flanking region of the human CRH gene in patients with RA (n = 310) and ethnically matched healthy controls (n = 305). In a subgroup of RA patients (n = 100) the autonomic response upon various standardised stressors was performed by utilising the heart rate variability (HRV) test (ProSciCard III, Version 2.2a, Medi-Syst GmbH, Germany) and compared to 45 age and sex matched osteoarthritis patients. To evaluate the impact of CRH promoter polymorphisms on the stress response in a subgroup of RA patients (n=18) an insulin hypoglycaemia test (IHT) was performed studying the dynamics of blood glucose levels, CRH, adrenocorticotropin (ACTH) and cortisol production.

Results: There was a highly significant distortion in the distribution of the beta2AR polymorphism at codon 16 between RA patients and controls, contributing to the genetic background of RA. Arginine (Arg) at codon 16 was present in 89.7 % of RA patients compared to 66.2 % controls (OR 4.43, 95 % CI 2.81 to 7.02, p = 0.00001). Stratifying RA patients for the amino acid sequence at position 16 and their autonomic reactivity revealed a statistically significant decrease of parasympathetic activity, in particular for the deep breathing test, in patients with homozygosity for Glycine (Gly) 16 compared to RA patients being heterozygous (Arg16Gly). However, RA patients with homozygosity for Glycine 16 showed a normalisation of the sympathetic reactivity upon mental stress test. On the other hand, polymorphisms of CRH 5’regulating region are differentially distributed in RA patients and healthy subjects. The CRH promoter polymorphisms exerted a significant influence on the stress response of RA patients undergoing an IHT. The integrated cortisol response to hypoglycaemia expressed as area under the curve was significantly lower in RA patients bearing the A1B1 allele (64154 ± 5768 nmol/l) compared to the A2B2 allele (91273 ± 7298 nmol/l, p=0.016).

Conclusion: Polymorphisms of the beta2AR and CRH contribute to the genetic background of RA and is associated with disturbed functional stress reactivity on various levels in these patients. Further studies are warranted to determine the role of genetic factors on stress response in the disease process of RA.


Disclosure:

O. Malysheva,
None;

C. G. Baerwald,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-markers-of-functional-stress-response-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology